My takeaways:

-Weekend ceasefire and truce fell flat in face; including its author
- GenViro Swift will be huge win for humanity. IMO, requires time in field test (medical professionals) before AtHome use; which will happen mid year, if approved
-GenConfirm could be the saving grace for humanity; offers assurance that your safe, i’m safe
- vision and design should get great acclaim
- diabetic strip portfolio still relevant; need GenChoice approved; last we heard it was in DECN, take a few bucks and make it happen; keep advancing TBG Précis for domestic
- shame DECN doesnt have portfolio in sakes channels; lack some street cred
- company great at design; sales still weak; communications/PR is amateurish (where is the under promise, over deliver); each PR is open invite for bashers and haters; either hire an expert or less is more;
- annual report is way too long; redundant; if needed OK; otherwise time needs to be devoted elsewhere
- product engineering is clear company strength
- good job with 13m;
- tea leaves say company sold, M&A, or license of tech sometime in summer; could be very lucrative
- really like Berman giving credit to M. Musho for design; that’s what leaders do! great job. ps-think
it’s also confirmation of future success!

Ok so let’s get this done DECN. World awaits. Need a win in this fight!

Drop swords! This fight is bigger than vendetta. We all know that. So IMO, it’s a greed play. Hired guns seem to show up everytime company takes step forward. Otherwise it’s low paid contract help spewing BS.

Count your blessings